Zimmer Biomet plummets 13% after weak third-quarter earnings report

Zimmer Biomet was dragging down the S&P Health Care sector Monday morning after cutting its sales guidance for the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.